CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial
CBT-I in PBT
Cognitive Behavioral Therapy for Insomnia in Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial
2 other identifiers
interventional
70
1 country
1
Brief Summary
This study seeks to investigate an evidence-based, manualized, behavioral health intervention, Cognitive Behavioral Therapy for Insomnia (CBT-I), in individuals with primary brain tumors (PBT) and insomnia. Our project will assess the feasibility and acceptability of recruitment, enrollment, data collection procedures, and retention of individuals with PBT and insomnia in the behavioral health intervention, CBT-I, and investigate the potential benefits of CBT-I within this at-risk and understudied population. In the long term, the goals are to expand treatment options for neuro-oncology patients and improve their mission readiness and overall wellbeing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Jul 2024
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 28, 2024
CompletedFirst Posted
Study publicly available on registry
June 3, 2024
CompletedStudy Start
First participant enrolled
July 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 25, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 25, 2025
CompletedOctober 1, 2025
September 1, 2025
1.2 years
May 28, 2024
September 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Rate of consent to screening procedures
Number of participants that consent to screening procedures
Baseline (Day 1)
Rate of those eligible enrolling
Number of participants that are eligible to enroll to the protocol
Baseline (Day 1)
Rate of baseline assessment completion
Number of participants that complete the baseline assessment
Week 1
Rate of post-intervention assessment completion
The number of participants that complete the post-intervention assessment
Week 6
Rate of follow-up assessment completion
The number of participants that complete the follow-up assessment
Week 18
Rate of intervention attrition
The number of participants that do not complete the CBT-I intervention
Week 6
Acceptability of quantity of assessments
Satisfaction rating of quantity of assessments on a scale of 1-5 with 5 being the best
Week 18
Acceptability of timing of assessments
Satisfaction ratings of timing of assessments on a scale of 1-5 with 5 being the best
Week 18
Acceptability of duration of assessments
Satisfaction ratings of duration of assessments on a scale of 1-5 with 5 being the best
Week 18
Study Arms (2)
Telehealth Cognitive Behavioral Therapy for Insomnia
EXPERIMENTALEnhanced Treatment as Usual
NO INTERVENTIONInterventions
CBT-I is a non-pharmacological approach to treating sleep disturbance consisting of educational, behavioral, and cognitive intervention components with evidence-based strategies including sleep efficiency, stimulus control, and sleep hygiene modification. CBT-I includes at least 6 group sessions, each approximately 90 minutes in length, delivered over 6 weeks via telehealth.
Eligibility Criteria
You may qualify if:
- Primary brain tumor diagnosis (grade I-IV)
- \>/=2weeks post-cranial resection (if applicable)
- \>/=1 month post-radiation therapy (if applicable)
- Able to understand, speak, and read English
- Absence of major cognitive concerns
- Meet Diagnostic and statistical manual of mental disorders version 5 (DSM-V) diagnostic criteria for insomnia
- Reliable internet connection
You may not qualify if:
- Major communication difficulties that would prohibit effective intervention
- Inability to attend weekly virtual group meetings
- Inability to understand and provide informed consent
- Currently a prisoner or residing in a correctional facility
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ashlee Loughan, Ph.D
Virginia Commonwealth University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 28, 2024
First Posted
June 3, 2024
Study Start
July 8, 2024
Primary Completion
September 25, 2025
Study Completion
September 25, 2025
Last Updated
October 1, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
There are no plans to share individual participant data.